Ana C Ricardo1, Juan E Grunwald2, Sharmila Parvathaneni3, Sean Goodin3, Alice Ching3, James P Lash3. 1. Department of Medicine, University of Illinois at Chicago, Chicago, IL. Electronic address: aricar2@uic.edu. 2. Scheie Eye Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA. 3. Department of Medicine, University of Illinois at Chicago, Chicago, IL.
Abstract
BACKGROUND: Retinopathy is associated with increased mortality risk in general populations. We evaluated the joint effect of retinopathy and chronic kidney disease (CKD) on mortality in a representative sample of U.S. adults. STUDY DESIGN: Prospective cohort study. SETTING & PARTICIPANTS: 7,640 adults from NHANES (National Health and Nutrition Examination Survey) 1988-1994 with mortality linkage through December 31, 2006. PREDICTORS: CKD, defined as low estimated glomerular filtration rate (<60 mL/min/1.73 m2) or albuminuria (urine protein-creatinine ratio ≥30 mg/g), and retinopathy, defined as the presence of microaneurysms, hemorrhages, exudates, microvascular abnormalities, or other evidence of diabetic retinopathy by fundus photograph. OUTCOMES: All-cause and cardiovascular mortality. MEASUREMENTS: Multivariable-adjusted Cox proportional hazards. RESULTS: Overall, 4.6% of participants had retinopathy and 15% had CKD. Mean age was 56 years, 53% were women, and 81% were non-Hispanic whites. The prevalence of retinopathy in patients with CKD was 11%. We identified 2,634 deaths during 14.5 years' follow-up. In multivariable analyses, compared with individuals with neither CKD nor retinopathy, HRs for all-cause mortality were 1.02 (95% CI, 0.75-1.38), 1.52 (95% CI, 1.35-1.72), and 2.39 (95% CI, 1.77-3.22) for individuals with retinopathy only, those with CKD only, and those with both CKD and retinopathy, respectively. Corresponding HRs for cardiovascular mortality were 0.96 (95% CI, 0.50-1.84), 1.72 (95% CI, 1.47-2.00), and 2.96 (95% CI, 2.11-4.15), respectively. There was a significant synergistic interaction between retinopathy and CKD on all-cause mortality (P=0.04). LIMITATIONS: The presence of retinopathy was evaluated only once. Small sample size of some of the subpopulations studied. CONCLUSIONS: In the presence of CKD, retinopathy is a strong predictor of mortality in this adult population.
BACKGROUND:Retinopathy is associated with increased mortality risk in general populations. We evaluated the joint effect of retinopathy and chronic kidney disease (CKD) on mortality in a representative sample of U.S. adults. STUDY DESIGN: Prospective cohort study. SETTING & PARTICIPANTS: 7,640 adults from NHANES (National Health and Nutrition Examination Survey) 1988-1994 with mortality linkage through December 31, 2006. PREDICTORS: CKD, defined as low estimated glomerular filtration rate (<60 mL/min/1.73 m2) or albuminuria (urine protein-creatinine ratio ≥30 mg/g), and retinopathy, defined as the presence of microaneurysms, hemorrhages, exudates, microvascular abnormalities, or other evidence of diabetic retinopathy by fundus photograph. OUTCOMES: All-cause and cardiovascular mortality. MEASUREMENTS: Multivariable-adjusted Cox proportional hazards. RESULTS: Overall, 4.6% of participants had retinopathy and 15% had CKD. Mean age was 56 years, 53% were women, and 81% were non-Hispanic whites. The prevalence of retinopathy in patients with CKD was 11%. We identified 2,634 deaths during 14.5 years' follow-up. In multivariable analyses, compared with individuals with neither CKD nor retinopathy, HRs for all-cause mortality were 1.02 (95% CI, 0.75-1.38), 1.52 (95% CI, 1.35-1.72), and 2.39 (95% CI, 1.77-3.22) for individuals with retinopathy only, those with CKD only, and those with both CKD and retinopathy, respectively. Corresponding HRs for cardiovascular mortality were 0.96 (95% CI, 0.50-1.84), 1.72 (95% CI, 1.47-2.00), and 2.96 (95% CI, 2.11-4.15), respectively. There was a significant synergistic interaction between retinopathy and CKD on all-cause mortality (P=0.04). LIMITATIONS: The presence of retinopathy was evaluated only once. Small sample size of some of the subpopulations studied. CONCLUSIONS: In the presence of CKD, retinopathy is a strong predictor of mortality in this adult population.
Authors: Matthew S Edwards; David B Wilson; Timothy E Craven; Jeanette Stafford; Linda F Fried; Tien Y Wong; Ronald Klein; Gregory L Burke; Kimberley J Hansen Journal: Am J Kidney Dis Date: 2005-08 Impact factor: 8.860
Authors: Daniel E Weiner; Sayed Tabatabai; Hocine Tighiouart; Essam Elsayed; Nisha Bansal; John Griffith; Deeb N Salem; Andrew S Levey; Mark J Sarnak Journal: Am J Kidney Dis Date: 2006-09 Impact factor: 8.860
Authors: Juan E Grunwald; Judith Alexander; Maureen Maguire; Revell Whittock; Candace Parker; Kathleen McWilliams; Joan C Lo; Raymond Townsend; Crystal A Gadegbeku; James P Lash; Jeffrey C Fink; Mahaboob Rahman; Harold Feldman; John Kusek; Akinlolu Ojo Journal: Clin J Am Soc Nephrol Date: 2010-03-18 Impact factor: 8.237
Authors: Josef Coresh; Elizabeth Selvin; Lesley A Stevens; Jane Manzi; John W Kusek; Paul Eggers; Frederick Van Lente; Andrew S Levey Journal: JAMA Date: 2007-11-07 Impact factor: 56.272
Authors: Charumathi Sabanayagam; Anoop Shankar; David Koh; Kee Seng Chia; Seang Mei Saw; Su Chi Lim; E Shyong Tai; Tien Yin Wong Journal: Am J Epidemiol Date: 2008-12-16 Impact factor: 4.897
Authors: Flavio E Hirai; Scot E Moss; Michael D Knudtson; Barbara E K Klein; Ronald Klein Journal: Am J Epidemiol Date: 2007-06-24 Impact factor: 4.897
Authors: Andrew S Levey; Lesley A Stevens; Christopher H Schmid; Yaping Lucy Zhang; Alejandro F Castro; Harold I Feldman; John W Kusek; Paul Eggers; Frederick Van Lente; Tom Greene; Josef Coresh Journal: Ann Intern Med Date: 2009-05-05 Impact factor: 25.391
Authors: Rupal Mehta; Alexander Hodakowski; Xuan Cai; Kris E Lee; Bryan R Kestenbaum; Ian H de Boer; Amani Fawzi; Tien Yin Wong; Joachim Ix; Barbara Klein; Ronald Klein; Tamara Isakova Journal: Ophthalmic Epidemiol Date: 2017-04-12 Impact factor: 1.648
Authors: Rupal Mehta; Gui Shuang Ying; Samuel Houston; Tamara Isakova; Lisa Nessel; Akinlolu Ojo; Alan Go; Jim Lash; John Kusek; Juan Grunwald; Myles Wolf Journal: Nephrol Dial Transplant Date: 2015-04-24 Impact factor: 5.992